NASDAQ: QDEL - Quidel

Yield per half year: -51.7%
Sector: Healthcare

Share chart Quidel


About

Quidel Corporation - крупный американский производитель диагностических медицинских продуктов, которые продаются по всему миру.

More details
8 мая 2020 года Управление по санитарному надзору за качеством пищевых продуктов и медикаментов США (FDA) выдало первое разрешение на использование в экстренных случаях (EUA) для теста на антиген COVID-19, новой категории тестов для использования в условиях продолжающейся пандемии. Эти диагностические тесты быстро обнаруживают фрагменты белков, обнаруженных на вирусе или внутри него, путем тестирования образцов, взятых из носовой полости, с помощью мазков.


Цена ао 34.15
P/E 44.05
P/S 6.01
P/BV 5.74
EV/EBITDA 31.34
EBITDA 0.1044
Сайт http://www.quidel.com
Число акций ао 0.0668 млрд
Выручка 0.5349
Див.доход ао 0
ISIN US2197981051
Change price per day: +8.14% (31.58)
Change price per week: +12.48% (30.36)
Change price per month: -8.49% (37.32)
Change price per 3 month: -15.26% (40.3)
Change price per half year: -51.7% (70.7)
Change price per year: -59.19% (83.69)
Change price per 3 year: -74.28% (132.77)
Change price per 5 year: -88.03% (285.35)
Change price per year to date: -54.48% (75.03)


All parameters ⇨

Underestimation

Title Value Grade
P/S 6.01 8
P/BV 5.74 9
P/E 44.05 9
EV/EBITDA 31.34 7
Total:

Efficiency

Title Value Grade
ROA, % -0.116 0
ROE, % -0.2032 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA 3.71 2
Total:

Growth impulse

Title Value Grade
Profit growth, % 103.14 10
Share price growth, % 62.84 10
Dividend growth, % 0 0
Total:

Institutions Volume Share, %
Carlyle Group Inc. 12460183 18.63
T. Rowe Price Investment Management, Inc. 8698143 13.01
Vanguard Group Inc 4841410 7.24
Blackrock Inc. 4798164 7.17
Senvest Management LLC 2999353 4.48
ArrowMark Colorado Holdings LLC 2663606 3.98
State Street Corporation 1530817 2.29
JP Morgan Chase & Company 1335012 2
Burgundy Asset Management Ltd. 1161485 1.74
Rubric Capital Management LP 980063 1.47

ETF Share, % Profitability for 1 year, % Dividends, %
Amplify Treatments Testing and Advancements ETF 3.55 71.57 1.06



Head Job title Payment Year of birth
Ruben Argueta Director of Investor Relations N/A
Ms. Michelle A. Hodges Senior VP, General Counsel & Secretary 1.8M 1961 (63 years)
Mr. Robert J. Bujarski J.D. Interim President, Executive VP & COO 2.62M 1969 (55 years)
Dr. Werner Kroll Ph.D. Senior Vice President of Research & Development 1.25M 1957 (67 years)
Mr. Joseph M. Busky CPA Chief Financial Officer 1.47M 1968 (56 years)
Mr. Michael S. Iskra Interim CEO, Executive VP & Chief Commercial Officer N/A 1970 (54 years)
Mr. Patrick E. Klein Chief Administrative Officer N/A
Mr. William J. Ferenczy Point of Care Business Unit Leader N/A 1956 (68 years)
Ms. Louise M. Brandy Chief Information Officer N/A
Ms. Tamara A. Ranalli Molecular Diagnostics Business Unit Leader N/A 1973 (51 year)

Address: United States, San Diego, CA , 9975 Summers Ridge Road - open in Google maps, open in Yandex maps
Website: http://www.quidel.com